AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.07%171.790.7%$1109.84m
AZNAstraZeneca Plc 0.47%58.231.2%$903.72m
PFEPfizer Inc. 0.60%41.720.9%$890.30m
MRKMerck & Co., Inc. 1.36%77.570.7%$790.23m
LLYEli Lilly & Co. 2.47%244.381.1%$746.32m
ABBVAbbVie, Inc. 0.50%118.131.9%$706.56m
BMYBristol-Myers Squibb Co. 0.50%68.301.0%$596.02m
GSKGlaxoSmithKline Plc 0.74%39.520.2%$189.86m
NRXPNRX Pharmaceuticals, Inc. 50.58%24.770.0%$151.02m
NVSNovartis AG 0.57%91.600.2%$150.50m
CERECerevel Therapeutics Holdings, Inc. -1.28%24.670.2%$150.47m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 2.88%126.460.0%$93.69m
VTRSViatris, Inc. 0.51%13.920.0%$87.35m
OGNOrganon & Co. -3.66%29.790.0%$83.69m
RPRXRoyalty Pharma Plc -0.07%40.330.2%$77.39m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.